Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 9 - Number 28


Cilostazol as a Unique Antithrombotic Agent

, 9(28): 2289 - 2302

Junichi Kambayashi, Yongge Liu, Bing Sun, Yasmin Shakur, Masuhiro Yoshitake and Frank Czerwiec


DOI: 10.2174/1381612033453910


ADP Receptors-Targets for Developing Antithrombotic Agents

, 9(28): 2303 - 2316

Satya P. Kunapuli, Zhongren Ding, Robert T. Dorsam, Soochong Kim, Swaminathan Murugappan and Todd M. Quinton


DOI: 10.2174/1381612033453947








Editor-in-Chief

Alessandro Antonelli
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)

Biography
View Full Editorial Board

Executive Editor

Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks.
Scopus CiteScore Metrics: 2.32

Advertisement

How to write and publish your papers in high impact journalsOctober Health DaysCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog